aTyr Pharma Announces Second Quarter 2022 Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
aTyr Pharma (LIFE) Misses Q2 EPS by 6c
August 15, 2022 4:02 PM EDTaTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
... More